186 related articles for article (PubMed ID: 25852645)
1. Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer.
Yoo HM; Park JH; Jeon YJ; Chung CH
Front Endocrinol (Lausanne); 2015; 6():36. PubMed ID: 25852645
[TBL] [Abstract][Full Text] [Related]
2. Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development.
Yoo HM; Kang SH; Kim JY; Lee JE; Seong MW; Lee SW; Ka SH; Sou YS; Komatsu M; Tanaka K; Lee ST; Noh DY; Baek SH; Jeon YJ; Chung CH
Mol Cell; 2014 Oct; 56(2):261-274. PubMed ID: 25219498
[TBL] [Abstract][Full Text] [Related]
3. Modification of ERα by UFM1 Increases Its Stability and Transactivity for Breast Cancer Development.
Yoo HM; Park JH; Kim JY; Chung CH
Mol Cells; 2022 Jun; 45(6):425-434. PubMed ID: 35680375
[TBL] [Abstract][Full Text] [Related]
4. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
5. MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression.
Zou R; Zhong X; Wang C; Sun H; Wang S; Lin L; Sun S; Tong C; Luo H; Gao P; Li Y; Zhou T; Li D; Cao L; Zhao Y
Int J Biol Sci; 2015; 11(9):992-1005. PubMed ID: 26221067
[TBL] [Abstract][Full Text] [Related]
6. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
Kim Y; Kim H; Jang SW; Ko J
Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
8. UFMylation: A Unique & Fashionable Modification for Life.
Wei Y; Xu X
Genomics Proteomics Bioinformatics; 2016 Jun; 14(3):140-146. PubMed ID: 27212118
[TBL] [Abstract][Full Text] [Related]
9. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
10. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.
Loven MA; Muster N; Yates JR; Nardulli AM
Mol Endocrinol; 2003 Jan; 17(1):67-78. PubMed ID: 12511607
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
12. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
Gong EY; Park E; Lee K
Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
[TBL] [Abstract][Full Text] [Related]
13. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
[TBL] [Abstract][Full Text] [Related]
14. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
15. Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.
González L; Zambrano A; Lazaro-Trueba I; Lopéz E; González JJ; Martín-Pérez J; Aranda A
Oncogene; 2009 Mar; 28(10):1298-308. PubMed ID: 19169277
[TBL] [Abstract][Full Text] [Related]
16. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
Matthews J; Wihlén B; Thomsen J; Gustafsson JA
Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
[TBL] [Abstract][Full Text] [Related]
20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
